Medytox Korea clinical trials
A subsidiary of Medy-Tox
The registry lists 3 studies whose lead sponsor is Medytox Korea. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jan 16, 2024.
Registry sponsor names on this page
- Medytox Korea3 studies
Something wrong with this grouping? Tell us on the Medy-Tox page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Medy-Tox studies →
- Long-term Extension Study to Evaluate MBA-P01 in Subjects With Moderate to Severe Glabellar LinesCompletedNCT05321979Phase 3
Sponsor listed in the registry: Medytox Korea
- A Phase II Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Moderate to Severe Glabellar LinesCompletedNCT05217355Phase 2
Sponsor listed in the registry: Medytox Korea
- Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Glabellar LinesCompletedNCT05059587Phase 3
Sponsor listed in the registry: Medytox Korea